Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
about
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsThe Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of MyofibroblastsHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepEvolving roles of circadian rhythms in liver homeostasis and pathologyMolecular Cues Guiding Matrix Stiffness in Liver FibrosisLoss of pericyte smoothened activity in mice with genetic deficiency of leptin.Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate CellsTriptolide mitigates radiation-induced pulmonary fibrosis via inhibition of axis of alveolar macrophages-NOXes-ROS-myofibroblasts.Pathophysiology of gadolinium-associated systemic fibrosisHepatoprotective effects of licochalcone B on carbon tetrachloride-induced liver toxicity in micePeripheral blood lymphocyte subset levels differ in patients with hepatocellular carcinoma.NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease.Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.Therapeutic potential of NADPH oxidase 1/4 inhibitors.New Developments on the Treatment of Liver Fibrosis.Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling.Liver inflammation and fibrosis.Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis.Hepatic stellate cells as key target in liver fibrosis.Feminization of male mouse liver by persistent growth hormone stimulation: Activation of sex-biased transcriptional networks and dynamic changes in chromatin states.Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.Ursolic acid suppresses TGF-β1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling.Hepatic Fibrosis in Dogs.Reactive oxygen species as signaling molecules in the development of lung fibrosis.Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated pro-tumorigenic interactions.Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.Hepatoprotective effect of methyl ferulic acid against carbon tetrachloride-induced acute liver injury in rats.Ursolic acid ameliorates CCl4-induced liver fibrosis through the NOXs/ROS pathway.The role of human cytochrome P450 2E1 in liver inflammation and fibrosis.Melatonin Attenuates Dysregulation of the Circadian Clock Pathway in Mice With CCl4-Induced Fibrosis and Human Hepatic Stellate Cells.Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
P2860
Q26745566-4A270B76-7E1A-4798-BA9C-87745140B98BQ26766479-60F50A8B-571F-41EF-A3B5-098E2DF2C160Q26771518-A31FF780-9AAF-4231-B872-8445F15FA4BAQ27010130-A15F0E50-92C1-4FF1-9F79-7E43ADF5BB47Q28077583-4B7D892F-02C8-4C71-9765-84F0447619FEQ33587672-A5C5B58A-6ABD-47F2-84D5-B0E3F66DE25AQ36026774-CC981A1C-9136-4F4D-810C-D44E9045012EQ37013220-2646A3BC-983F-4F31-9CAD-34443F9ED6DAQ37139482-42993960-8D20-495B-8648-EE844AABDE64Q37306955-EE008EBA-0B0E-4361-8442-495D2A567A8AQ37718399-B87E1A67-6ABB-42DE-9A05-AF04E26750CDQ37739608-6F3763EB-4078-40B7-AB77-C2A55C6CB23FQ38649653-7950BF78-5D7C-4003-8234-CD88C0AC5A9AQ38681686-27D6CE3E-0998-4197-98AA-C9F232ED76D6Q38858553-A110A137-E2C0-4987-8A7B-7BA72EEDB9CCQ38873303-4BABED2A-1DF5-4F7D-9759-9F7BAC02C963Q38972122-BB1455BE-E487-4509-97E8-BEDA8BAFC413Q39065620-815609D2-21B8-4C8E-9801-20CCAA8C66A4Q39429850-07E525B6-6154-43CC-8D34-219F1872AC22Q39738492-9AAC7775-3F4F-477C-867A-70B6937FC244Q40200602-6627395B-1DBE-4698-9244-BC6D9CCC5CC1Q41042951-2FD9BB4C-13B7-4330-8C1D-AE6B751E1ACEQ41643115-6BE391E2-7CA6-460E-A1AF-0360F27880C9Q42376330-299304FF-9414-4C10-A915-6F4FB180FB6DQ46250177-AFBB560F-56A2-4660-BD4C-DE11B41865E3Q46272741-523869C7-3487-4D98-963B-53A226878EB1Q50020648-C502EFA9-FDD0-4034-A66D-1B351EAFFD1EQ50092600-5063AEA9-0975-47B4-80AD-129B1AEB3B50Q50207629-655400D0-2D9D-47CD-B027-9AFC91598EBEQ52577750-025BBA44-CC5F-4951-A77D-7F3FF357E6EBQ55129692-F45D94D1-E5AB-4C5E-A1E1-B2E727CA277BQ55262346-F5DD61A5-8D22-4DD1-8570-815B1A634B67Q58754397-2C1229C1-2221-4DD0-A847-8047EF67D212
P2860
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Deficiency of NOX1 or NOX4 Pre ...... atic Stellate Cell Activation.
@ast
Deficiency of NOX1 or NOX4 Pre ...... atic Stellate Cell Activation.
@en
type
label
Deficiency of NOX1 or NOX4 Pre ...... atic Stellate Cell Activation.
@ast
Deficiency of NOX1 or NOX4 Pre ...... atic Stellate Cell Activation.
@en
prefLabel
Deficiency of NOX1 or NOX4 Pre ...... atic Stellate Cell Activation.
@ast
Deficiency of NOX1 or NOX4 Pre ...... atic Stellate Cell Activation.
@en
P2860
P1433
P1476
Deficiency of NOX1 or NOX4 Pre ...... atic Stellate Cell Activation.
@en
P2093
Tatiana Kisseleva
P2860
P304
P356
10.1371/JOURNAL.PONE.0129743
P407
P577
2015-07-29T00:00:00Z